Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)
Clinical trial NCT00288431 · COMPLETED
Trial details
- NCT number
- NCT00288431
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2008-07-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.